Long-term safety study of KRP-AB1102

Long-term safety study of KRP-AB1102 in japanese patients with chronic obstructive pulmonary disease (COPD)

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221930

Enrollment

130

Registered

2012-09-27

Start date

2012-09-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

investigational material(s) Generic name etc : KRP-AB1102 INN of investigational material : Therapeutic category code : 229 Other agents affecting respiratory organs Dosage and Administration for Inv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult male or female COPD patients aged >= 40, and others.

Exclusion criteria

Exclusion criteria: - History or current diagnosis of asthma - Patient changed drug treatment for COPD within 4 weeks prior to screening visit, and others.

Design outcomes

Primary

Measure	Time frame
Adverse events, and others Vital signs	—

Secondary

Measure	Time frame
Trough FEV1, and others. The change from baseline	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026